Despite unequivocal evidences causally link IL-1β to the development of obesity-associated comorbities, IL-18, also activated by caspase-1, has been shown to ameliorate the development of obesity and insulin resistance (126). This evidence concerns the gene CASP1 and obesity due to melanocortin 4 receptor deficiency.